Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/02/200213132623.htm
No comments:
Post a Comment